Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer
The data suggest that despite the heterogeneity in CRC, genomic evolution increases the impact of recurrent alterations, and integrating information about tumor primary location and genomics can be used to predict organ-specific metastasis risk.